1800 103 7100
info@mohanfoundation.org
MOHAN Foundation

Menu

Skip to content
  • About
  • Free Downloads
  • Videos

Newlink Genetics' Pancreatic Cancer Vaccine Likely To Disappoint Investors In … – Seeking Alpha

December 31, 2012Transplant Rejectionadmin

Newlink Genetics' Pancreatic Cancer Vaccine Likely To Disappoint Investors In ...
Seeking Alpha
Alpha-Gal residues are powerful antigens that cause a rapid, hyperacute rejection response whenever foreign tissues bearing them are introduced into the human body. Thus the goal of the Hyperacute(R) platform is to train the patient's immune system to ...

Post navigation

← Why IMA wants a board to lay down rules for international patient transfer – Firstpost Life savers back organ donor appeal – Motherwell Times →

Categories

  • Antibodies
  • Blood donation
  • Bone marrow donation and transplantation
  • Brain Death Declaration
  • Chronic Allograft Nephropathy
  • Donor Card
  • Drugs/Medicine
  • Google News RSS feed URL deprecation
  • Heart
  • HLA Typing
  • Immunosuppressive Drugs
  • Infectious Disease
  • Intestinal
  • Islet
  • Kidney
  • Liver
  • Lung
  • Monoclonal Anti-CD20 Antibodies
  • Monoclonal Anti-IL-2Rα Receptor Antibodies
  • Nephrology
  • Organ Donation
  • Organ Donor
  • Organ Failure
  • Organ Preservation Methods
  • Organ Preservation Solution
  • Organs
  • Other Transplantation
  • Pancreas
  • Pharma News
  • Polyclonal Anti-T-Cell Antibodies
  • Tissue Donation
  • Transplant laws
  • Transplant Rejection
  • Transplant Studies
  • Transplant Surgery
  • Transplant Tourism
  • Transplant Trials
  • Transplantation
  • Uncategorized
Copyright © MOHAN Foundation
Powered by WordPress , Theme i-excel by TemplatesNext.
MENU
    • About
    • Free Downloads
    • Videos